Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells - PubMed (original) (raw)
Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells
X R Bustelo et al. Science. 1992.
Abstract
Activation of B lymphocytes by engagement of their immunoglobulin M antigen receptors results in phosphorylation of a number of proteins on tyrosine residues. One such protein is p95vav, the product of the vav proto-oncogene. Tyrosine phosphorylation of p95vav occurred within seconds of immunoglobulin M cross-linking and was independent of other events induced during stimulation of B cells, such as protein kinase C activation, guanosine triphosphate-binding protein signaling, and calcium mobilization. Moreover, engagement of antigen receptors induced the rapid (approximately 5 seconds) and transient (approximately 60 seconds) association of p95vav with a 70-kilodalton tyrosine-phosphorylated protein, Vap-1, an interaction mediated by the Src homology 2 domain of p95vav. These results suggest that the vav proto-oncogene participates in the signaling processes that mediate the antigen-induced activation of B lymphocytes.
Similar articles
- Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells.
Platanias LC, Sweet ME. Platanias LC, et al. J Biol Chem. 1994 Feb 4;269(5):3143-6. J Biol Chem. 1994. PMID: 7508909 - Insulin-dependent tyrosine phosphorylation of the vav protooncogene product in cells of hematopoietic origin.
Uddin S, Katzav S, White MF, Platanias LC. Uddin S, et al. J Biol Chem. 1995 Mar 31;270(13):7712-6. doi: 10.1074/jbc.270.13.7712. J Biol Chem. 1995. PMID: 7535775 - Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates.
Bustelo XR, Ledbetter JA, Barbacid M. Bustelo XR, et al. Nature. 1992 Mar 5;356(6364):68-71. doi: 10.1038/356068a0. Nature. 1992. PMID: 1311423 - Structure and function of vav.
Romero F, Fischer S. Romero F, et al. Cell Signal. 1996 Dec;8(8):545-53. doi: 10.1016/s0898-6568(96)00118-0. Cell Signal. 1996. PMID: 9115846 Review. - Vav links antigen-receptor signaling to the actin cytoskeleton.
Fischer KD, Tedford K, Penninger JM. Fischer KD, et al. Semin Immunol. 1998 Aug;10(4):317-27. doi: 10.1006/smim.1998.0124. Semin Immunol. 1998. PMID: 9695188 Review.
Cited by
- The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity.
Billadeau DD, Mackie SM, Schoon RA, Leibson PJ. Billadeau DD, et al. J Exp Med. 2000 Aug 7;192(3):381-92. doi: 10.1084/jem.192.3.381. J Exp Med. 2000. PMID: 10934226 Free PMC article. - Vav1 transduces T cell receptor signals to the activation of phospholipase C-gamma1 via phosphoinositide 3-kinase-dependent and -independent pathways.
Reynolds LF, Smyth LA, Norton T, Freshney N, Downward J, Kioussis D, Tybulewicz VL. Reynolds LF, et al. J Exp Med. 2002 May 6;195(9):1103-14. doi: 10.1084/jem.20011663. J Exp Med. 2002. PMID: 11994416 Free PMC article. - Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells.
Dosil M, Wang S, Lemischka IR. Dosil M, et al. Mol Cell Biol. 1993 Oct;13(10):6572-85. doi: 10.1128/mcb.13.10.6572-6585.1993. Mol Cell Biol. 1993. PMID: 7692230 Free PMC article. - Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.
Katzav S. Katzav S. Oncotarget. 2015 Oct 6;6(30):28731-42. doi: 10.18632/oncotarget.5086. Oncotarget. 2015. PMID: 26353933 Free PMC article. Review. - New transgenic mouse models enabling pan-hematopoietic or selective hematopoietic stem cell depletion in vivo.
Rodriguez Y Baena A, Rajendiran S, Manso BA, Krietsch J, Boyer SW, Kirschmann J, Forsberg EC. Rodriguez Y Baena A, et al. Sci Rep. 2022 Feb 24;12(1):3156. doi: 10.1038/s41598-022-07041-6. Sci Rep. 2022. PMID: 35210475 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous